Brivaracetam Patent Expiration
Brivaracetam is used for managing partial-onset seizures in patients with epilepsy aged 4 years and older. It was first introduced by Ucb Inc
Brivaracetam Patents
Given below is the list of patents protecting Brivaracetam, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Briviact | US10729653 | Pharmaceutical compositions comprising 2-oxo-1-pyrrolidine derivatives | Apr 09, 2030 | Ucb Inc |
| Briviact | US6784197 | 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
Feb 21, 2021
(Expired) | Ucb Inc |
| Briviact | US6911461 | 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses | Feb 21, 2026 | Ucb Inc |
| Briviact | US8492416 | 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
Feb 21, 2021
(Expired) | Ucb Inc |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Brivaracetam Generics
Several generic applications have been filed for Brivaracetam. The first generic version for Brivaracetam was by Sunshine Lake Pharma Co Ltd and was approved on Jun 9, 2022. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Jan 6, 2023.
Given below is the list of companies who have filed for Brivaracetam generic.
1. SUNSHINE
Sunshine Lake Pharma Co Ltd has filed for 5 different strengths of generic version for Brivaracetam. Given below are the details of the strengths of this generic introduced by Sunshine.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Discontinued | ORAL | N/A | Jun 9, 2022 |
| 25MG | tablet | Discontinued | ORAL | N/A | Jun 9, 2022 |
| 50MG | tablet | Discontinued | ORAL | N/A | Jun 9, 2022 |
| 75MG | tablet | Discontinued | ORAL | N/A | Jun 9, 2022 |
| 100MG | tablet | Discontinued | ORAL | N/A | Jun 9, 2022 |
2. LUPIN LTD
Lupin Ltd has filed for 5 different strengths of generic version for Brivaracetam. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 25MG | tablet | Discontinued | ORAL | N/A | Dec 20, 2022 |
| 75MG | tablet | Discontinued | ORAL | N/A | Dec 20, 2022 |
| 100MG | tablet | Discontinued | ORAL | N/A | Dec 20, 2022 |
| 10MG | tablet | Discontinued | ORAL | N/A | Dec 20, 2022 |
| 50MG | tablet | Discontinued | ORAL | N/A | Dec 20, 2022 |
3. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 5 different strengths of generic version for Brivaracetam. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Discontinued | ORAL | N/A | Oct 3, 2022 |
| 25MG | tablet | Discontinued | ORAL | N/A | Oct 3, 2022 |
| 50MG | tablet | Discontinued | ORAL | N/A | Oct 3, 2022 |
| 75MG | tablet | Discontinued | ORAL | N/A | Oct 3, 2022 |
| 100MG | tablet | Discontinued | ORAL | N/A | Oct 3, 2022 |
4. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Brivaracetam. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 100MG | tablet | Discontinued | ORAL | N/A | Jan 6, 2023 |
| 50MG | tablet | Discontinued | ORAL | N/A | Jan 6, 2023 |